患者的声音:长期抗精神病药物治疗决策过程的实践经验
Refael Yonatan-Leus1, Nili Karako-Eyal2
1The Department of Psychology, The College of Management Academic Studies, Elie Wiesel St 2, Rishon Le'Zion, Israel. refael.yonatan@mail.huji.ac.il.
Community mental health journal
|December 13, 2024
概括
由于对依赖和戒断的初始信息缺口,患者经常面临长期抗精神病治疗的挑战. 这可能导致一个循环,当他们试图修改治疗时,他们的自主性受到侵蚀.
科学领域:
- 精神病学是一个精神病学.
- 心理健康研究 心理健康研究
- 以患者为中心的护理
背景情况:
- 长期使用抗精神病药物是治疗严重精神疾病的基石.
- 了解患者在决策中的经验对于改善治疗坚持和结果至关重要.
- 现有的研究往往侧重于临床疗效,而不是患者通过治疗的旅程.
研究的目的:
- 探索患者对长期抗精神病治疗决策过程的看法.
- 确定患者体验中可能影响自主性的主题.
- 了解抗精神病治疗中决策挑战的周期性.
主要方法:
- 定性研究涉及20名接受非强制性抗精神病药物治疗的患者的半结构面试.
- 基于理论的方法被用于数据分析.
- 主题分析的重点是识别患者账户中反复出现的模式.
主要成果:
- 一个周期性的过程出现了,其特点是关于依赖,戒断和治疗持续时间的初始有限信息.
- 患者经常希望停止或减少药物治疗,但面临副作用或治疗无效的驳回.
- 在尝试治疗修改时,报告了缺乏感知到的替代品和精神病学家的反对.
结论:
- 最初的信息缺陷有助于一个循环,可以在长期抗精神病治疗中侵蚀患者的自主权.
- 提供全面的信息和验证患者经验至关重要.
- 治疗过程应积极增强患者的自主权和精神病治疗中的共享决策.
相关概念视频
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Psychosis and Antipsychotic Drugs: Overview
176
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
176
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Mania and Antimanic Drugs: Overview
135
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
135
Antipsychotic Drugs: Therapeutic Uses and Side Effects
120
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
120
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219


